Covalon Technologies (TSE:COV) has released an update.
Covalon Technologies Ltd. is set to exhibit their innovative vascular access solutions at the 2024 Association for Vascular Access Annual Scientific Meeting in Colorado, demonstrating their dedication to improving patient care. The company will feature products designed for patient comfort and infection control, including CovaClear® IV dressings and a range of patented technologies that prevent contamination.
For further insights into TSE:COV stock, check out TipRanks’ Stock Analysis page.
